DK1291352T3 - 6-O-substituerede ketolider med antibakteriel aktivitet - Google Patents

6-O-substituerede ketolider med antibakteriel aktivitet

Info

Publication number
DK1291352T3
DK1291352T3 DK02024559T DK02024559T DK1291352T3 DK 1291352 T3 DK1291352 T3 DK 1291352T3 DK 02024559 T DK02024559 T DK 02024559T DK 02024559 T DK02024559 T DK 02024559T DK 1291352 T3 DK1291352 T3 DK 1291352T3
Authority
DK
Denmark
Prior art keywords
alkyl
substituted
heteroaryl
aryl
optionally substituted
Prior art date
Application number
DK02024559T
Other languages
Danish (da)
English (en)
Inventor
Yat Sun Or
Zhenkun Ma
Richard F Clark
Daniel T Chu
Jacob J Plattner
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27107953&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1291352(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/888,350 external-priority patent/US5866549A/en
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of DK1291352T3 publication Critical patent/DK1291352T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cephalosporin Compounds (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK02024559T 1996-09-04 1997-09-02 6-O-substituerede ketolider med antibakteriel aktivitet DK1291352T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70777696A 1996-09-04 1996-09-04
US08/888,350 US5866549A (en) 1996-09-04 1997-07-03 6-O-substituted ketolides having antibacterial activity

Publications (1)

Publication Number Publication Date
DK1291352T3 true DK1291352T3 (da) 2005-09-19

Family

ID=27107953

Family Applications (5)

Application Number Title Priority Date Filing Date
DK02024557T DK1291350T3 (da) 1996-09-04 1997-09-02 6-0-substituerede ketolider med antibakteriel aktivitet
DK02024559T DK1291352T3 (da) 1996-09-04 1997-09-02 6-O-substituerede ketolider med antibakteriel aktivitet
DK97939765T DK0929563T3 (da) 1996-09-04 1997-09-02 6-O-substituerede ketolider med antibakteriel aktivitet
DK02024558T DK1291351T3 (da) 1996-09-04 1997-09-02 6-O-substituerede ketolider med antibakteriel aktivitet
DK02024560T DK1291353T3 (da) 1996-09-04 1997-09-02 6-O-substituerede ketolider med antibakteriel aktivitet

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK02024557T DK1291350T3 (da) 1996-09-04 1997-09-02 6-0-substituerede ketolider med antibakteriel aktivitet

Family Applications After (3)

Application Number Title Priority Date Filing Date
DK97939765T DK0929563T3 (da) 1996-09-04 1997-09-02 6-O-substituerede ketolider med antibakteriel aktivitet
DK02024558T DK1291351T3 (da) 1996-09-04 1997-09-02 6-O-substituerede ketolider med antibakteriel aktivitet
DK02024560T DK1291353T3 (da) 1996-09-04 1997-09-02 6-O-substituerede ketolider med antibakteriel aktivitet

Country Status (27)

Country Link
US (4) US6147197A (cs)
EP (5) EP1291352B1 (cs)
JP (1) JP4597274B2 (cs)
KR (5) KR20050044816A (cs)
CN (4) CN1680419A (cs)
AT (5) ATE296831T1 (cs)
BG (1) BG63547B1 (cs)
BR (1) BR9711661A (cs)
CA (1) CA2263972C (cs)
CZ (1) CZ300106B6 (cs)
DE (5) DE69733370T2 (cs)
DK (5) DK1291350T3 (cs)
ES (5) ES2242812T3 (cs)
HR (5) HRP970473B1 (cs)
HU (1) HU230166B1 (cs)
ID (1) ID19406A (cs)
IL (1) IL128681A0 (cs)
NO (1) NO314230B1 (cs)
NZ (1) NZ334274A (cs)
PL (1) PL188173B1 (cs)
PT (5) PT1291351E (cs)
RO (1) RO121473B1 (cs)
RU (1) RU2192427C2 (cs)
SI (1) SI20023B (cs)
SK (5) SK285536B6 (cs)
TR (1) TR199901127T2 (cs)
WO (1) WO1998009978A1 (cs)

Families Citing this family (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6495348B1 (en) 1993-10-07 2002-12-17 Regents Of The University Of Minnesota Mitomycin biosynthetic gene cluster
UA51730C2 (uk) * 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
AP1060A (en) * 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
DE69908855T2 (de) 1998-04-24 2004-05-19 Pfizer Products Inc., Groton 9a, 11b-dehydro Derivative von 9-oxime-3-keto-6-0-methylerythromycin
US6265202B1 (en) 1998-06-26 2001-07-24 Regents Of The University Of Minnesota DNA encoding methymycin and pikromycin
FR2780977B1 (fr) * 1998-07-09 2000-09-01 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
JP4573925B2 (ja) * 1998-07-09 2010-11-04 アベンティス・ファーマ・ソシエテ・アノニム 新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用
FR2792637B1 (fr) * 1999-04-26 2001-06-01 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2785612A1 (fr) * 1998-11-10 2000-05-12 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
CN1376160A (zh) * 1998-11-03 2002-10-23 辉瑞产品公司 新的大环内酯抗生素
AU3517700A (en) * 1999-03-15 2000-10-04 Abbott Laboratories 6-o-substituted macrolides having antibacterial activity
US6939861B2 (en) 1999-04-16 2005-09-06 Kosan Biosciences, Inc. Amido macrolides
KR20020007374A (ko) 1999-04-16 2002-01-26 추후제출 매크롤라이드 항감염제
US6451768B1 (en) 1999-04-16 2002-09-17 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6514944B2 (en) 1999-04-16 2003-02-04 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6420535B1 (en) * 1999-06-07 2002-07-16 Abbott Laboratories 6-O-carbamate ketolide derivatives
ATE250076T1 (de) * 1999-06-07 2003-10-15 Abbott Lab 6-o-carbamat ketolide derivate
US6437106B1 (en) * 1999-06-24 2002-08-20 Abbott Laboratories Process for preparing 6-o-substituted erythromycin derivatives
US6417366B2 (en) * 1999-06-24 2002-07-09 Abbott Laboratories Preparation of quinoline-substituted carbonate and carbamate derivatives
EP1101769A3 (en) 1999-11-18 2001-10-24 Pfizer Products Inc. Nitrogen containing erythromycin derivatives
US6472372B1 (en) 2000-12-06 2002-10-29 Ortho-Mcneil Pharmaceuticals, Inc. 6-O-Carbamoyl ketolide antibacterials
AU2002316550A1 (en) * 2001-07-03 2003-01-21 Chiron Corporation C12 modified erythromycin macrolides and ketolides having antibacterial activity
JP2005503416A (ja) 2001-09-17 2005-02-03 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド 6−o−カルバメート−11,12−ラクト−ケトライド抗菌剤
US6673774B2 (en) * 2001-12-03 2004-01-06 Enanta Pharmaceuticals, Inc. 11-O-substituted macrolides and their descladinose derivatives
CN1585775A (zh) 2001-12-05 2005-02-23 奥索-麦克尼尔药品公司 可用作抗菌药的红霉素的6-o-酰基酮内酯衍生物
US6831068B2 (en) * 2002-02-13 2004-12-14 Abbott Laboratories Macrolide antibacterial compounds
US20030162729A1 (en) * 2002-02-13 2003-08-28 Zhenkun Ma Macrolides with activity against methicillin-resistant staphylococcus aureus
CA2476223A1 (en) * 2002-02-13 2003-08-21 Abbott Laboratories Macrolide antibacterial compounds
EP2316469A1 (en) 2002-02-22 2011-05-04 Shire LLC Delivery system and methods for protecting and administering dextroamphetamine
US6995143B2 (en) 2002-02-28 2006-02-07 Basilea Pharmaceutica Ag Macrolides with antibacterial activity
US7910558B2 (en) * 2002-05-13 2011-03-22 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
US6841664B2 (en) * 2002-07-25 2005-01-11 Enanra Pharmaceuticals, Inc. 6,11-4-carbon bridged ketolides
US7273853B2 (en) * 2002-05-13 2007-09-25 Enanta Pharmaceuticals, Inc. 6-11 bicyclic ketolide derivatives
CN1671726A (zh) * 2002-05-31 2005-09-21 詹森药业有限公司 3-脱克拉定糖基-6-o-氨基甲酰基和6-o-烷氧基羰基大环内酯抗菌药
JPWO2004078771A1 (ja) * 2003-03-07 2006-06-08 大正製薬株式会社 2−フルオロ−6−o−置換ケトライド誘導体
ES2552682T3 (es) 2003-03-10 2015-12-01 Merck Sharp & Dohme Corp. Agentes antibacterianos novedosos
JP2006524706A (ja) * 2003-04-25 2006-11-02 カイロン コーポレイション 新規なケトライド誘導体
US6790835B1 (en) * 2003-06-05 2004-09-14 Enanta Pharmaceuticals, Inc. Bicyclic macrolide derivatives
US20040254126A1 (en) * 2003-06-05 2004-12-16 Yao-Ling Qiu 11-12 Bicyclic erythromycin derivatives
EP1670808A1 (en) * 2003-09-12 2006-06-21 Chiron Corporation Antimicrobial derivatives
GB0327720D0 (en) 2003-11-28 2003-12-31 Biotica Tech Ltd Erythromycins and process for their preparation
WO2005067564A2 (en) * 2004-01-07 2005-07-28 Enanta Pharmaceuticals, Inc. 6-11 bicyclic erythromycin derivatives
US7265094B2 (en) * 2004-01-09 2007-09-04 Enanta Pharmaceuticals, Inc. 9N-substituted 6-11 bicyclic erythromycin derivatives
US7384921B2 (en) * 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
RU2397987C2 (ru) * 2004-07-28 2010-08-27 Рэнбакси Лабораториз Лимитед Кетолидные производные в качестве антибактериальных агентов
EP1771456A2 (fr) * 2004-07-30 2007-04-11 Palumed SA Molecules hybrides qa ou q est une aminoquinoleine et a est un residu antibiotique, leur synthese et leurs utilisations en tant qu'agent antibacterien
FR2874922A1 (fr) * 2004-07-30 2006-03-10 Palumed Sa Molecules hybrides qa ou q est une aminoquinoleine et a est un residu antibiotique, leur synthese et leurs utilisations en tant qu'agent antibacterien
TW200635600A (en) * 2004-12-13 2006-10-16 Enanta Pharm Inc Tetracyclic bicyclolides
UA85937C2 (uk) 2004-12-21 2009-03-10 Пфайзер Продактс Інк. Макроліди
US7384922B2 (en) * 2005-05-04 2008-06-10 Enanta Pharmaceuticals, Inc. 6-11 bridged oxime erythromycin derivatives
US7517859B2 (en) * 2005-05-04 2009-04-14 Enanta Pharmaceuticals, Inc. Spirocyclic bicyclolides
US20060252710A1 (en) * 2005-05-04 2006-11-09 Guoqiang Wang 6-11 Bridged oxime erythromycin derivatives
WO2007091393A1 (ja) 2006-02-07 2007-08-16 Taisho Pharmaceutical Co., Ltd. 10a-アザライド化合物
CA2661538A1 (en) 2006-08-24 2008-02-28 Wockhardt Research Centre Novel macrolides and ketolides having antimicrobial activity
JPWO2009019868A1 (ja) 2007-08-06 2010-10-28 大正製薬株式会社 10a、12位架橋型10a−アザライド化合物
US8273720B2 (en) * 2007-09-17 2012-09-25 Enanta Pharmaceuticals, Inc. 6,11-bicyclolides: bridged biaryl macrolide derivatives
ES2691252T3 (es) * 2007-09-17 2018-11-26 Enanta Pharmaceuticals, Inc. Macrólidos de biarilo con puente en 6,11
US8354383B2 (en) * 2007-09-17 2013-01-15 Enanta Pharmaceuticals, Inc. 6,11-bridged biaryl macrolides
CN101917850B (zh) 2007-10-25 2016-01-13 森普拉制药公司 大环内酯类抗菌剂的制备方法
TW200946109A (en) * 2008-05-09 2009-11-16 Enanta Pharm Inc Anti-bacterial activity of 9-hydroxy derivatives 6, 11-bicyclolides
WO2009139181A1 (ja) 2008-05-15 2009-11-19 大正製薬株式会社 4員環構造を有する10a-アザライド化合物
ES2677007T3 (es) 2008-10-24 2018-07-27 Cempra Pharmaceuticals, Inc. Procedimientos para tratar enfermedades resistentes usando macrólidos que contienen triazol
JP5607149B2 (ja) 2009-05-27 2014-10-15 ウォックハート リサーチ センター 抗菌活性を有するケトライド化合物
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
US9480679B2 (en) 2009-09-10 2016-11-01 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and MAC diseases
US8975386B2 (en) 2010-03-22 2015-03-10 Cempra Pharmaceuticals, Inc. Crystalline forms of a macrolide, and uses therefor
DK2571506T3 (en) 2010-05-20 2017-08-28 Cempra Pharmaceuticals Inc PROCEDURES FOR THE MANUFACTURE OF MACROLIDES AND KETOLIDES AND INTERMEDIATES
US8796474B1 (en) 2010-08-23 2014-08-05 Rutgers, The State University Of New Jersey Macrolide compounds and methods and intermediates useful for their preparation
JP6042334B2 (ja) 2010-09-10 2016-12-14 センプラ ファーマシューティカルズ,インコーポレイテッド 疾患治療のための水素結合形成フルオロケトライド
EP2673285B1 (en) 2010-12-09 2017-07-19 Wockhardt Limited Ketolide compounds
AR085286A1 (es) * 2011-02-21 2013-09-18 Taisho Pharmaceutical Co Ltd Derivado de macrolido sustituido en la posicion c-4
JP5718488B2 (ja) 2011-03-01 2015-05-13 ウォックハート リミテッド ケトライド中間体の調製方法
KR101795838B1 (ko) 2011-03-22 2017-11-08 욱크하르트 리미티드 케톨리드 화합물의 제조 방법
CN102766181A (zh) * 2011-05-06 2012-11-07 上海医药工业研究院 6-o-取代的红霉素衍生物的制备方法
CN102766089A (zh) * 2011-05-06 2012-11-07 上海医药工业研究院 3-(3-喹啉基)-2-丙烯-1-卤代物及其制备方法
US10188674B2 (en) * 2012-03-27 2019-01-29 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
JP5857008B2 (ja) * 2012-08-20 2016-02-10 大正製薬株式会社 C−4”位置換マクロライド誘導体を含有する医薬
GB201217310D0 (en) 2012-09-27 2012-11-14 C10 Pharma As Compounds
JP6426696B2 (ja) 2013-03-14 2018-11-21 センプラ ファーマシューティカルズ,インコーポレイテッド 呼吸器疾患の治療のための方法および製剤
RU2015138797A (ru) 2013-03-15 2017-04-24 Семпра Фармасьютикалс, Инк. Конвергентные способы получения макролидных антибактериальных агентов
AR102810A1 (es) 2014-08-18 2017-03-29 Taisho Pharmaceutical Co Ltd Derivado de macrólido sustituido en la posición c-4
WO2018067663A2 (en) * 2016-10-04 2018-04-12 Biopharmati Sa Ketolides having antibacterial activity
WO2018161039A1 (en) 2017-03-03 2018-09-07 Synovo Gmbh Novel anti-infective and anti-inflammatory compounds
CN109942653B (zh) * 2019-02-27 2021-06-25 北京理工大学 一种红霉素衍生物及其制备方法
IL293115A (en) * 2019-12-02 2022-07-01 Aliquantumrx Inc Salts and polymorphs of cethromycin for the treatment of disease Salts and polymorphs of cethromycin
CN113817008B (zh) * 2021-07-15 2023-05-23 湖州师范学院 新型琥珀酰基十六元大环内酯的制备方法及用途

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670549A (en) * 1985-03-18 1987-06-02 Taisho Pharmaceutical Co., Ltd. Method for selective methylation of erythromycin a derivatives
KR960000434B1 (ko) * 1986-12-17 1996-01-06 다이쇼 세이야꾸 가부시끼가이샤 에리스로마이신 a유도체 및 그의 제조 방법
KR930702369A (ko) * 1990-10-15 1993-09-08 우에노 아키라 에리쓰로마이신 또는 그의 유도체의 2'위치 수식 화합물
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of erythromycin derivatives
KR0166096B1 (ko) * 1990-11-28 1999-01-15 우에하라 아키라 6-0-메틸에리쓰로마이신 a 유도체
WO1993013663A1 (en) * 1992-01-17 1993-07-22 Abbott Laboratories Method of directing biosynthesis of specific polyketides
US5523399A (en) * 1991-12-27 1996-06-04 Taisho Pharmaceutical Co., Ltd. 5-O-desosaminylerythronolide derivatives
CA2093303C (en) * 1992-04-09 1998-11-24 Abraham Araya Aluminosilicates
JP3259429B2 (ja) * 1992-04-22 2002-02-25 大正製薬株式会社 5−o−デソサミニルエリスロノライドa誘導体
US5591837A (en) * 1992-04-22 1997-01-07 Taisho Pharmaceutical Co., Ltd. 5-O-desosaminylerythronolide a derivative
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2697524B1 (fr) * 1992-11-05 1994-12-23 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2702480B1 (fr) * 1993-03-09 1995-04-28 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2713226B1 (fr) * 1993-12-03 1996-01-05 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2732023B1 (fr) * 1995-03-22 1997-04-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2732684B1 (fr) * 1995-04-06 1997-04-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2738571B1 (fr) * 1995-09-11 1997-10-17 Roussel Uclaf Nouveaux derives de la 5-0-desosaminyl 6-0-methyl- erythronolide a, leur procede de preparation et leur application a la preparation de produits biologiquement actifs
US6274715B1 (en) * 1995-11-08 2001-08-14 Abbott Laboratories Tricyclic erythromycin derivatives
KR19990067492A (ko) * 1995-11-08 1999-08-25 스티븐 에프. 웨인스톡 트리사이클릭 에리트로마이신 유도체
UA51730C2 (uk) * 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
AU4472797A (en) * 1996-10-31 1998-05-22 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
US6171807B1 (en) * 1996-11-13 2001-01-09 Associates Of Cape Cod, Inc. Detection and quantitation of endotoxin by fluorescence polarization

Also Published As

Publication number Publication date
US6147197A (en) 2000-11-14
KR100568455B1 (ko) 2006-04-07
CA2263972A1 (en) 1998-03-12
CZ300106B6 (cs) 2009-02-11
EP1291350A1 (en) 2003-03-12
AU729348B2 (en) 2001-02-01
ES2242812T3 (es) 2005-11-16
EP1291351B1 (en) 2005-07-13
NO991022L (no) 1999-05-03
NO314230B1 (no) 2003-02-17
KR100610043B1 (ko) 2006-08-08
PT929563E (pt) 2005-10-31
DE69733439T2 (de) 2006-05-04
EP0929563B1 (en) 2005-06-01
AU4178097A (en) 1998-03-26
CN1680420A (zh) 2005-10-12
CA2263972C (en) 2008-01-29
DK0929563T3 (da) 2005-10-03
EP1291353B1 (en) 2005-06-01
SK285535B6 (sk) 2007-03-01
PT1291353E (pt) 2005-10-31
EP1291350B1 (en) 2005-05-25
KR20050043993A (ko) 2005-05-11
PL332009A1 (en) 1999-08-16
SI20023A (sl) 2000-02-29
BG103292A (en) 1999-12-30
EP1291353A1 (en) 2003-03-12
CN100441591C (zh) 2008-12-10
DE69733723T2 (de) 2006-04-20
PT1291351E (pt) 2005-11-30
RU2192427C2 (ru) 2002-11-10
ATE296831T1 (de) 2005-06-15
US6075133A (en) 2000-06-13
PT1291350E (pt) 2005-09-30
DE69733422T2 (de) 2006-05-04
SK28699A3 (en) 2000-03-13
ATE296832T1 (de) 2005-06-15
HRP20060278A2 (en) 2007-10-31
DE69733369D1 (de) 2005-06-30
WO1998009978A1 (en) 1998-03-12
DE69733369T2 (de) 2006-01-26
PL188173B1 (pl) 2004-12-31
TR199901127T2 (xx) 1999-07-21
KR20050044816A (ko) 2005-05-12
HRP20060275A2 (en) 2007-10-31
ATE299508T1 (de) 2005-07-15
NZ334274A (en) 2001-02-23
DK1291350T3 (da) 2005-09-26
USRE39591E1 (en) 2007-04-24
DE69733723D1 (de) 2005-08-18
EP1291352B1 (en) 2005-05-25
SK286181B6 (sk) 2008-04-07
CN1237183A (zh) 1999-12-01
HU230166B1 (hu) 2015-09-28
ES2242813T3 (es) 2005-11-16
IL128681A0 (en) 2000-01-31
SK285533B6 (sk) 2007-03-01
HRP20060275B1 (hr) 2014-04-11
HK1021537A1 (en) 2000-06-16
DE69733439D1 (de) 2005-07-07
ES2242983T3 (es) 2005-11-16
ATE296308T1 (de) 2005-06-15
CN1680418A (zh) 2005-10-12
ES2244716T3 (es) 2005-12-16
RO121473B1 (ro) 2007-06-29
JP4597274B2 (ja) 2010-12-15
BG63547B1 (bg) 2002-04-30
BR9711661A (pt) 1999-08-24
KR20000068435A (ko) 2000-11-25
SK285534B6 (sk) 2007-03-01
DE69733370D1 (de) 2005-06-30
EP1291352A1 (en) 2003-03-12
KR100576988B1 (ko) 2006-05-10
HRP970473A2 (en) 1998-08-31
HRP20060278B1 (hr) 2014-04-11
KR20050043994A (ko) 2005-05-11
ID19406A (id) 1998-07-09
SI20023B (en) 2001-02-28
DK1291353T3 (da) 2005-10-03
DK1291351T3 (da) 2005-10-24
HRP20060277B1 (hr) 2014-04-11
CZ68599A3 (cs) 1999-08-11
DE69733422D1 (de) 2005-07-07
US6028181A (en) 2000-02-22
EP0929563A1 (en) 1999-07-21
KR20050044815A (ko) 2005-05-12
DE69733370T2 (de) 2006-02-02
ATE296307T1 (de) 2005-06-15
CN100460415C (zh) 2009-02-11
HUP9902869A3 (en) 2001-04-28
HRP20060276B1 (hr) 2014-04-25
KR100523679B1 (ko) 2005-10-26
SK285536B6 (sk) 2007-03-01
HRP20060277A2 (en) 2007-10-31
HUP9902869A2 (hu) 2000-02-28
PT1291352E (pt) 2005-09-30
EP1291351A1 (en) 2003-03-12
JP2001500855A (ja) 2001-01-23
ES2242811T3 (es) 2005-11-16
HRP970473B1 (en) 2007-02-28
HRP20060276A2 (en) 2007-10-31
CN1273475C (zh) 2006-09-06
NO991022D0 (no) 1999-03-02
CN1680419A (zh) 2005-10-12

Similar Documents

Publication Publication Date Title
DK0929563T3 (da) 6-O-substituerede ketolider med antibakteriel aktivitet
CA2096969A1 (en) 6-0-methylerythromycin a derivatives
EP0107201A3 (en) Phenyl-substituted tricyclic antibacterial agents
KR890005124A (ko) 세펨 화합물 및 이의 제조방법
CA2149496A1 (en) 11,21-bisphenyl-19-norpregnane derivatives
EP0765865A4 (en) 2-ACYLAMINOPROPANOL COMPOUND AND MEDICINAL COMPOSITION
NZ237351A (en) Cephalosporin derivative, medicaments, intermediate compound
EP0677522A4 (en) 8-METHOXYCHINOLONE CARBONIC ACID DERIVATIVES.
CA2195031A1 (en) Quinolinone derivative and anti-allergic agent with said quinolinone derivative as the active ingredient
HUP9902893A2 (hu) 6-O-Szubsztituált eritromicinszármazékok és eljárás előállításukra
NZ334317A (en) beta-lactam compounds as antibacterial agents effective against methicillin-resistant and coagulase-negative Staphylococci and process for preparing the same
IE43346L (en) Cephalosporin derivatives.
CA2194399A1 (en) Novel carbapenem derivative
Neu Lomefloxacin: Development of a once-a-day quinolone
HUP9903423A3 (en) 3-descladinose-2,3-anhydroerythromycin derivatives
EP0926139A4 (en) CHINOLINE SULFIDE DERIVATIVES
ES8707188A1 (es) Procedimiento para la preparacion de compuestos de actividad antibacteriana
ZA972324B (en) Novel herbicides.
CA2564377A1 (en) 6-o-substituted ketolides having antibacterial activity
AU4899896A (en) Hetero-aromatic ring substituted phenyloxazolidinone antimicrobials